Neuropeptides and nerve growth in inflammatory bowel diseases: A quantitative immunohistochemical study

Digestive Diseases and Sciences

Volumn 47, Issue 3, 2002, Pages 495-502

  Lee, C M Y ^a   Kumar, R K ^a   Lubowski, D Z ^b   Burcher, E ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST GEORGE HOSPITAL   (Australia)

Author keywords

Growth associated protein 43; Immunohistochemistry; Nerve growth factor; Substance P; Vasoactive intestinal peptide

Indexed keywords

NERVE GROWTH FACTOR; NEUROMODULIN; NEUROPEPTIDE; NEUROTROPHIN RECEPTOR; PROTEIN P75; SUBSTANCE P; VASOACTIVE INTESTINAL POLYPEPTIDE;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CELL COUNT; CELL DENSITY; CELL GROWTH; CLINICAL ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; MALE; NERVE GROWTH; NEUROPATHOLOGY; NEUTROPHIL; PATHOPHYSIOLOGY; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; ULCERATIVE COLITIS;

ADULT; AGED; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; FEMALE; GAP-43 PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; MALE; MIDDLE AGED; NERVE FIBERS; NERVE GROWTH FACTORS; NEUROPEPTIDES; NEUTROPHILS; RECEPTOR, NERVE GROWTH FACTOR; SUBSTANCE P; VASOACTIVE INTESTINAL PEPTIDE;

EID: 0036124724     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1017943430627     Document Type: Article

References (35)

1. The immunomodulation of enteric neuromuscular function: Implications for motility and inflammatory disorders
2. Changes in substance P-immunoreactive innervation of human colon associated with ulcerative colitis
3. Implications of tachykinins and calcitonin gene-related peptide in inflammatory bowel disease
4. Plasma-VIP in ulcerative colitis
5. Abnormalities of vasoactive intestinal polypeptide-containing nerves in Crohn's disease
6. Peptide-containing nerve fibres in the gut wall in Crohn's disease
7. Vasoactive intestinal peptide concentrations and immunocytochemical studies in rectal biopsies from patients with inflammatory bowel disease
8. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases
9. Vasoactive intestinal peptide as a laboratory supplement to clinical activity index in inflammatory bowel disease
10. Colonic substance P levels are increased in ulcerative colitis and decreased in chronic severe constipation
11. Plasma vasoactive intestinal polypeptide concentration determination in patients with diarrhea
12. Immunocytochemical localization of vasoactive intestinal peptide and substance P in the colon from normal subjects and patients with inflammatory bowel disease
13. Rectal substance P concentrations are increased in ulcerative colitis but not in Crohn's disease
14. Gut hormones in inflammatory bowel disease
15. Colonic vasoactive intestinal polypeptide in ulcerative colitis
16. Colonic vasoactive intestinal polypeptide(VIP) in ulcerative colitis - A radioimmunoassay and immunohistochemical study
17. Abnormal neuropeptide concentration in rectal mucosa of patients with inflammatory bowel disease
18. Substance P containing nerve fibers in rectal mucosa of ulcerative colitis
19. Substance P and vasoactive intestinal polypeptide but not calcitonin gene-related peptide concentrations are reduced in patients with moderate and severe ulcerative colitis
20. Substance P containing nerve fibers in ulcerative colitis
21. Subcellular localization of phosphoprotein B-50 in regenerating muscle. An immunoelectron microscopic study
22. Neuronal damage and plasticity identified by microtubule-associate protein 2, growth-associated protein 43, and cyclin D1 immunoreactivity after focal cerebral ischemia in rats
23. Neuroimmune appendicitis
24. Mast cells and gut nerve development: Implications for Hirschsprung's disease and intestinal neuronal dysplasia
25. p75 and Trk: A two-receptor system
26. Peripheral cell types contributing to the hyperalgesic action of nerve growth factor in inflammation
27. Nerve growth factor and Trk high affinity receptor (TrkA) gene expression in inflammatory bowel disease
28. Receptor binding sites for substance P, but not substance K or neuromedin K, are expressed in high concentrations by arterioles, venules, and lynph nodules in surgical specimens obtained from patients with ulcerative colitis and Crohn disease
29. Receptors for sensory neuropeptides in human inflammatory diseases: Implications for the effector role of sensory neurons
30. Differential expression of substance P receptors in patients with Crohn's disease and ulcerative colitis
31. Neuropeptide expression in cultures of adult sensory neurons: Modulation of substance P and calcitonin gene-related peptide levels by nerve growth factor
32. Decreased CGRP but preserved TrkA immunoreactivity in nerve fibres in inflamed human superficial temporal arteries
33. V. Genes, lineages, and tissue interactions in the development of the enteric nervous system
34. Projections of nitric oxide synthase and vasoactive intestinal polypeptide-reactive submucosal neurons in the human colon
35. Elevated density and plasticity of nerve fibres in anal fissures